ORASURE TECHNOLOGIES INC
Nasdaq: OSURSurgical & Medical Instruments & Apparatus · Entity-resolved by Clous
Key financials
Short interest & fails
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
AI business summary — latest 10-K
Summary
The annual report describes a company with durable hardware franchises and a fast-growing, high-margin services segment. Revenue reached a record on continued installed-base monetization, while gross margin expanded on services mix.
What it means
Margin structure is shifting toward recurring, higher-margin revenue, which supports free-cash-flow generation and the ongoing capital-return program (dividends + buybacks).
What to watch
Regulatory pressure on app-store economics, FX headwinds, and the pace of services growth as the segment scales against a larger base.
Generated from public filings · not investment advice
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $387.48M | $405.47M | $185.83M | $115.02M | -38.1% | 100% |
| Net Income | -$17.93M | $53.66M | -$19.5M | -$68.73M | -252.5% | -60% |
| Total Assets | $444.71M | $482.85M | $479.66M | $403.17M | -15.9% | 351% |
| Equity | $363.62M | $430.67M | $410.34M | $340.83M | -16.9% | 296% |
| Operating Cash Flow | -$47.2M | $141.58M | $27.37M | -$49.02M | -279.1% | -43% |
| Shares Outstanding | — | — | — | 69.13M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001116463